Target Price | $2,637.59 |
Price | $2,450.00 |
Potential | 7.66% |
Number of Estimates | 22 |
22 Analysts have issued a price target MercadoLibre 2026 . The average MercadoLibre target price is $2,637.59. This is 7.66% higher than the current stock price. The highest price target is $3,100.00 26.53% , the lowest is $2,250.00 8.16% . | |
A rating was issued by 26 analysts: 22 Analysts recommend MercadoLibre to buy, 3 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the MercadoLibre stock has an average upside potential 2026 of 7.66% . Most analysts recommend the MercadoLibre stock at Purchase. |
20 Analysts have issued a sales forecast MercadoLibre 2025 . The average MercadoLibre sales estimate is $26.3b . This is 17.54% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $28.2b 25.81% , the lowest is $25.0b 11.81% .
This results in the following potential growth metrics:
2024 | $20.8b | 37.53% |
---|---|---|
2025 | $26.3b | 26.60% |
2026 | $32.7b | 24.18% |
2027 | $39.2b | 19.99% |
2028 | $49.6b | 26.45% |
20 Analysts have issued an MercadoLibre EBITDA forecast 2025. The average MercadoLibre EBITDA estimate is $4.2b . This is 20.35% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.1b 46.79% , the lowest is $3.7b 6.80% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $3.1b | 18.53% |
---|---|---|
2025 | $4.2b | 35.83% |
2026 | $5.6b | 32.64% |
2027 | $7.2b | 28.95% |
2028 | $10.0b | 39.24% |
2024 | 14.93% | 13.81% |
---|---|---|
2025 | 16.02% | 7.30% |
2026 | 17.11% | 6.80% |
2027 | 18.39% | 7.48% |
2028 | 20.25% | 10.11% |
11 MercadoLibre Analysts have issued a net profit forecast 2025. The average MercadoLibre net profit estimate is $2.4b . This is 18.69% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.0b 44.94% , the lowest is $2.0b 3.94% .
This results in the following potential growth metrics and future Net Margins:
2024 | $1.9b | 94.78% |
---|---|---|
2025 | $2.4b | 28.01% |
2026 | $3.4b | 39.11% |
2027 | $4.5b | 31.26% |
2024 | 9.20% | 41.63% |
---|---|---|
2025 | 9.30% | 1.12% |
2026 | 10.42% | 12.04% |
2027 | 11.40% | 9.40% |
11 Analysts have issued a MercadoLibre forecast for earnings per share. The average MercadoLibre EPS is $48.25 . This is 18.70% higher than earnings per share in the financial year 2024. The highest EPS forecast is $58.92 44.94% , the lowest is $39.05 3.94% .
This results in the following potential growth metrics and future valuations:
2024 | $37.69 | 94.78% |
---|---|---|
2025 | $48.25 | 28.02% |
2026 | $67.12 | 39.11% |
2027 | $88.10 | 31.26% |
Current | 59.28 | 18.88% |
---|---|---|
2025 | 49.95 | 15.74% |
2026 | 35.91 | 28.11% |
2027 | 27.36 | 23.81% |
Based on analysts' sales estimates for 2025, the MercadoLibre stock is valued at an EV/Sales of 4.66 and an P/S ratio of 4.64 .
This results in the following potential growth metrics and future valuations:
Current | 5.47 | 5.39% |
---|---|---|
2025 | 4.66 | 14.85% |
2026 | 3.75 | 19.47% |
2027 | 3.13 | 16.66% |
2028 | 2.47 | 20.92% |
Current | 5.46 | 4.15% |
---|---|---|
2025 | 4.64 | 14.92% |
2026 | 3.74 | 19.47% |
2027 | 3.12 | 16.66% |
2028 | 2.47 | 20.92% |
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Overweight
➜
Overweight
|
Unchanged | May 08 2025 |
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Apr 16 2025 |
Benchmark |
➜
Buy
|
Initiated | Apr 15 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 10 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Mar 03 2025 |
JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Feb 25 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 21 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 08 2025 |
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Apr 16 2025 |
Initiated
Benchmark:
➜
Buy
|
Apr 15 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 10 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Mar 03 2025 |
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Feb 25 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.